New patent for Horizon drug VIMOVO

Annual Drug Patent Expirations for VIMOVO Vimovo is a drug marketed by Horizon and is included in one NDA. It is available from two suppliers. There are three patents protecting…

The post New patent for Horizon drug VIMOVO appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog